Filing Details
- Accession Number:
- 0001209191-12-044791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-07 19:39:58
- Reporting Period:
- 2012-09-05
- Filing Date:
- 2012-09-07
- Accepted Time:
- 2012-09-07 19:39:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 831547 | Spectrum Pharmaceuticals Inc | SPPI | Pharmaceutical Preparations (2834) | 930979187 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193918 | Md C Rajesh Shrotriya | 11500 S. Eastern Ave. Suite 240 Henderson NV 89052 | Chairman, Ceo & President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-09-05 | 33,000 | $12.53 | 2,432,934 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-09-06 | 34,000 | $12.63 | 2,398,934 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 11, 2012 and/or pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 18, 2012.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.57, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.53 to $12.70, inclusive. The reporting person undertakes to provide to Spectrum Pharmaceuticals, Inc., any security holder of Spectrum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
